InterStim Therapy System, Verify Evaluation System
Medtronic Neuromodulation · Decision date Sep 14, 2026
What did the FDA decide?
FDA database entry P080025/S352 records a 30-Day Notice for the InterStim Therapy System and Verify Evaluation System. The decision, dated September 14, 2026, is OK30, and the stated change is the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers.
The supplement type is a Process Change involving manufacturer, sterilizer, packager, or supplier. The applicant is Medtronic Neuromodulation. The source statement reports the purpose of the notice but does not provide independent proof of safety or clinical effectiveness, and no new indication or clinical benefit is stated.
FDA approval order statement
the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 14, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P080025/S352
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Neuromodulation
- Product code
- QON
- Decision code
- OK30
- Decision date
- Sep 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implanted electrical device intended for treatment of fecal incontinence.
- Applicant
- Medtronic Neuromodulation
- Product code
- QON
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P080025. Subsequent supplements may change the device or its indications.
FDA decision timeline
P080025 · Original PMA
MEDTRONIC INTERSTIM SACRAL NERVE STIMULATION THERAPY SYSTEM
P080025/S352 received
Application receipt date recorded by FDA.
P080025/S352 · FDA decision
30-Day Notice
P080025/S351 · Related supplement
lnterStim Therapy System, Verify Evaluation System
P080025/S353 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S354 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800), (SNS Bowel Neurostimulators Impl
Timeline entries are records held by MedtechLedger for P080025. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P080025
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Neuromodulation | PMA approval | Mar 14, 2011 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 9, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 29, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Neuromodulation
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Ms Rcw225, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P080025/S352
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


